Cyclooxygenase-2 enhances α2β1 integrin expression and cell migration via EP1 dependent signaling pathway in human chondrosarcoma cells

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Liu, Ju Fang ^a   Fong, Yi Chin ^a,b   Chang, Chih Shiang ^a   Huang, Chun Yin ^c   Chen, Hsien Te ^b   Yang, Wei Hung ^c   Hsu, Chin Jung ^a,b   Jeng, Long Bin ^b   Chen, Chih Yi ^b   Tang, Chih Hsin ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY BEIGANG HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUTANT PROTEIN; PHOSPHOLIPASE C BETA3; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROTEIN KINASE C ALPHA; PROTEIN KINASE P60; SMALL INTERFERING RNA; VERY LATE ACTIVATION ANTIGEN 2; PHOSPHOLIPASE C; PROSTANOID RECEPTOR EP1; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; PTGS2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CELL MIGRATION; CHONDROSARCOMA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METASTASIS; PROTEIN PROTEIN INTERACTION; SARCOMA CELL; SIGNAL TRANSDUCTION; UPREGULATION; CELL MOTION; DRUG EFFECT; ENZYMOLOGY; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; CELL MOVEMENT; CHONDROSARCOMA; CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRIN ALPHA2BETA1; MALE; MIDDLE AGED; NF-KAPPA B; PROTEIN KINASE C; RECEPTORS, PROSTAGLANDIN E; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TYPE C PHOSPHOLIPASES; UP-REGULATION;

EID: 77649313651     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-43     Document Type: Article

References (47)

1. Terek RM, Schwartz GK, Devaney K, Glantz L, Mak S, Healey JH, Albino AP. Chemotherapy and P-glycoprotein expression in chondrosarcoma. J Orthop Res 1998, 16:585-590. 10.1002/jor.1100160510, 9820282.
2. Yuan J, Dutton CM, Scully SP. RNAi mediated MMP-1 silencing inhibits human chondrosarcoma invasion. J Orthop Res 2005, 23:1467-1474.
3. Warner TD, Mitchell JA. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J 2004, 18:790-804. 10.1096/fj.03-0645rev, 15117884.
4. Morita I. Distinct functions of COX-1 and COX-2. Prostaglandins Other Lipid Mediat 2002, 68-69:165-175. 10.1016/S0090-6980(02)00029-1, 12432916.
5. Turini ME, DuBois RN. Cyclooxygenase-2: a therapeutic target. Annu Rev Med 2002, 53:35-57. 10.1146/annurev.med.53.082901.103952, 11818462.
6. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, Hla T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995, 55:3785-3789.
7. Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S, Ogawa M, Mitsudomi T, Sugiura T, Takahashi T. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 1998, 58:3761-3764.
8. Hwang D, Scollard D, Byrne J, Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 1998, 90:455-460. 10.1093/jnci/90.6.455, 9521170.
9. Tucker ON, Dannenberg AJ, Yang EK, Zhang F, Teng L, Daly JM, Soslow RA, Masferrer JL, Woerner BM, Koki AT, Fahey TJ. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 1999, 59:987-990.
10. Suzawa T, Miyaura C, Inada M, Maruyama T, Sugimoto Y, Ushikubi F, Ichikawa A, Narumiya S, Suda T. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 2000, 141:1554-1559. 10.1210/en.141.4.1554, 10746663.
11. Weinreb M, Machwate M, Shir N, Abramovitz M, Rodan GA, Harada S. Expression of the prostaglandin E(2) (PGE(2)) receptor subtype EP(4) and its regulation by PGE(2) in osteoblastic cell lines and adult rat bone tissue. Bone 2001, 28:275-281. 10.1016/S8756-3282(00)00447-6, 11248657.
12. Watabe A, Sugimoto Y, Honda A, Irie A, Namba T, Negishi M, Ito S, Narumiya S, Ichikawa A. Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor. J Biol Chem 1993, 268:20175-20178.
13. Katsuyama M, Nishigaki N, Sugimoto Y, Morimoto K, Negishi M, Narumiya S, Ichikawa A. The mouse prostaglandin E receptor EP2 subtype: cloning, expression, and northern blot analysis. FEBS Lett 1995, 372:151-156. 10.1016/0014-5793(95)00966-D, 7556658.
14. Sugimoto Y, Namba T, Honda A, Hayashi Y, Negishi M, Ichikawa A, Narumiya S. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype. J Biol Chem 1992, 267:6463-6466.
15. Jain RK, Fenton BT. Intratumoral lymphatic vessels: a case of mistaken identity or malfunction?. J Natl Cancer Inst 2002, 94:417-421.
16. Humphries MJ. Integrin structure. Biochem Soc Trans 2000, 28:311-339. 10.1042/0300-5127:0280311, 10961914.
17. Yao ES, Zhang H, Chen YY, Lee B, Chew K, Moore D, Park C. Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res 2007, 67:659-664. 10.1158/0008-5472.CAN-06-2768, 17234776.
18. Nikkola J, Vihinen P, Vlaykova T, Hahka-Kemppinen M, Heino J, Pyrhonen S. Integrin chains beta1 and alphav as prognostic factors in human metastatic melanoma. Melanoma Res 2004, 14:29-37. 10.1097/00008390-200402000-00005, 15091191.
19. Muller-Klingspor V, Hefler L, Obermair A, Kaider A, Breitenecker G, Leodolte S, Kohlberger P. Prognostic value of beta1-integrin (=CD29) in serous adenocarcinomas of the ovary. Anticancer Res 2001, 21:2185-2188.
20. Heyder C, Gloria-Maercker E, Hatzmann W, Niggemann B, Zanker KS, Dittmar T. Role of the beta1-integrin subunit in the adhesion, extravasation and migration of T24 human bladder carcinoma cells. Clin Exp Metastasis 2005, 22:99-106. 10.1007/s10585-005-4335-z, 16086230.
21. Seales EC, Jurado GA, Brunson BA, Wakefield JK, Frost AR, Bellis SL. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Res 2005, 65:4645-4652. 10.1158/0008-5472.CAN-04-3117, 15930282.
22. Takenaka K, Shibuya M, Takeda Y, Hibino S, Gemma A, Ono Y, Kudoh S. Altered expression and function of beta1 integrins in a highly metastatic human lung adenocarcinoma cell line. Int J Oncol 2000, 17:1187-1194.
23. Rozic JG, Chakraborty C, Lala PK. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis. Int J Cancer 2001, 93:497-506. 10.1002/ijc.1376, 11477553.
24. Kozaki K, Koshikawa K, Tatematsu Y, Miyaishi O, Saito H, Hida T, Osada H, Takahashi T. Multi-faceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicry of inflammatory cells in metastasis. Oncogene 2001, 20:4228-4234. 10.1038/sj.onc.1204561, 11464289.
25. Fulton AM, Ma X, Kundu N. Targeting prostaglandin E EP receptors to inhibit metastasis. Cancer Res 2006, 66:9794-9797. 10.1158/0008-5472.CAN-06-2067, 17047037.
26. Fedorov Y, Anderson EM, Birmingham A, Reynolds A, Karpilow J, Robinson K, Leake D, Marshall WS, Khvorova A. Off-target effects by siRNA can induce toxic phenotype. RNA 2006, 12:1188-1196. 10.1261/rna.28106, 1484448, 16682561.
27. Lai TH, Fong YC, Fu WM, Yang RS, Tang CH. Stromal cell-derived factor-1 increase alphavbeta3 integrin expression and invasion in human chondrosarcoma cells. J Cell Physiol 2009, 218:334-342. 10.1002/jcp.21601, 18814143.
28. Tang CH, Yang RS, Fu WM. Prostaglandin E2 stimulates fibronectin expression through EP1 receptor, phospholipase C, protein kinase Calpha, and c-Src pathway in primary cultured rat osteoblasts. J Biol Chem 2005, 280:22907-22916. 10.1074/jbc.M500130200, 15833739.
29. Madrid LV, Mayo MW, Reuther JY, Baldwin AS. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 2001, 276:18934-18940. 10.1074/jbc.M101103200, 11259436.
30. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006, 127:679-695. 10.1016/j.cell.2006.11.001, 17110329.
31. Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Cancer Res 2002, 62:6323-6328.
32. Ma L, del Soldato P, Wallace JL. Divergent effects of new cyclooxygenase inhibitors on gastric ulcer healing: Shifting the angiogenic balance. Proc Natl Acad Sci USA 2002, 99:13243-13247. 10.1073/pnas.202392199, 130618, 12232050.
33. Dohadwala M, Batra RK, Luo J, Lin Y, Krysan K, Pold M, Sharma S, Dubinett SM. Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion. J Biol Chem 2002, 277:50828-50833. 10.1074/jbc.M210707200, 1471886, 12393872.
34. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 2000, 69:145-182. 10.1146/annurev.biochem.69.1.145, 10966456.
35. Chiu YC, Shieh DC, Tong KM, Chen CP, Huang KC, Chen PC, Fong YC, Hsu HC, Tang CH. Involvement of AdipoR receptor in adiponectin-induced motility and alpha2beta1 integrin upregulation in human chondrosarcoma cells. Carcinogenesis 2009, 30:1651-1659. 10.1093/carcin/bgp156, 19549705.
36. Lin MT, Chang CC, Lin BR, Yang HY, Chu CY, Wu MH, Kuo ML. Elevated expression of Cyr61 enhances peritoneal dissemination of gastric cancer cells through integrin alpha2beta1. J Biol Chem 2007, 282:34594-34604. 10.1074/jbc.M706600200, 17905740.
37. Kawashima A, Kawahara E, Tokuda R, Nakanishi I. Tumour necrosis factor-alpha provokes upregulation of alpha2beta1 and alpha5beta1 integrins, and cell migration in OST osteosarcoma cells. Cell Biol Int 2001, 25:319-329. 10.1006/cbir.2000.0652, 11319838.
38. Berk BC, Taubman MB, Cragoe EJ, Fenton JW, Griendling KK. Thrombin signal transduction mechanisms in rat vascular smooth muscle cells. Calcium and protein kinase C-dependent and -independent pathways. J Biol Chem 1990, 265:17334-17340. 2.
39. Yeh M, Gharavi NM, Choi J, Hsieh X, Reed E, Mouillesseaux KP, Cole AL, Reddy ST, Berliner JA. Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src/signal transducers and activators of transcription (STAT)3 pathway. J Biol Chem 2004, 279:30175-30181. 10.1074/jbc.M312198200, 15143062.
40. Yang M, Zhang H, Voyno-Yasenetskaya T, Ye RD. Requirement of Gbetagamma and c-Src in D2 dopamine receptor-mediated nuclear factor-kappaB activation. Mol Pharmacol 2003, 64:447-455. 10.1124/mol.64.2.447, 12869650.
41. Su JL, Shih JY, Yen ML, Jeng YM, Chang CC, Hsieh CY, Wei LH, Yang PC, Kuo ML. Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Res 2004, 64:554-564. 10.1158/0008-5472.CAN-03-1301, 14744769.
42. Tang CH, Tan TW, Fu WM, Yang RS. Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis. Carcinogenesis 2008, 29:35-43. 10.1093/carcin/bgm220, 17916907.
43. Tan TW, Yang WH, Lin YT, Hsu SF, Li TM, Kao ST, Chen WC, Fong YC, Tang CH. Cyr61 increases migration and MMP-13 expression via alphavbeta3 integrin, FAK, ERK and AP-1-dependent pathway in human chondrosarcoma cells. Carcinogenesis 2009, 30:258-268. 10.1093/carcin/bgn284, 19126648.
44. Liang JA, Wu SL, Lo HY, Hsiang CY, Ho TY. Vanillin inhibits matrix metalloproteinase-9 expression through down-regulation of nuclear factor-kappaB signaling pathway in human hepatocellular carcinoma cells. Mol Pharmacol 2009, 75:151-157. 10.1124/mol.108.049502, 18835982.
45. Fong YC, Dutton CM, Cha SS, Garamszegi N, Sim FH, Scully SP. Absence of a correlation between the presence of a single nucleotide polymorphism in the matrix metalloproteinase 1 promoter and outcome in patients of chondrosarcoma. Clin Cancer Res 2004, 10:7329-7334. 10.1158/1078-0432.CCR-04-0900, 15534109.
46. Yang SN, Chen HT, Tsou HK, Huang CY, Yang WH, Su CM, Fong YC, Tseng WP, Tang CH. Leptin enhances cell migration in human chondrosarcoma cells through OBRl leptin receptor. Carcinogenesis 2009, 30:566-574. 10.1093/carcin/bgp023, 19168585.
47. Hsu HC, Fong YC, Chang CS, Hsu CJ, Hsu SF, Lin JG, Fu WM, Yang RS, Tang CH. Ultrasound induces cyclooxygenase-2 expression through integrin, integrin-linked kinase, Akt, NF-kappaB and p300 pathway in human chondrocytes. Cell Signal 2007, 19:2317-2328. 10.1016/j.cellsig.2007.07.006, 17692505.